Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.
about
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® VaccinePhase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine.Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.Do vitamin D levels affect antibody titers produced in response to HPV vaccine?Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKDFour-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.HPV prophylactic vaccines: lessons learned from 10 years experience
P2860
Q30251868-C8A8BEC2-7FDB-4878-90E2-0A7103F1978CQ35818648-85D4EA20-9120-42EB-AC8E-21CF64F3CEABQ35887407-541B32C4-4EC7-47BB-B9F3-C4F6302AEE30Q35887777-A2EF3CCF-568A-4A4F-9FD3-C8E124A0CFB8Q35901974-0BBC4C6C-001A-4925-9612-AB1481769E7BQ36256414-8AE6359F-AB79-4584-97A8-1DC200581A82Q36874555-C995E3D9-91A7-4DB3-9B52-B43E53E8B9BAQ38380284-6346F6E1-58F5-4DE0-85D5-0A5A57FF2890Q38671633-87D9E6D8-80C7-4124-BBF8-3D9816433CF8Q40293794-73572F03-83AF-4B26-BD87-6985F4E4E8DFQ47549756-52DFD82C-A21C-4B56-8CA9-12E7F4832DFDQ56067928-68B78E79-0DCD-44A0-B4AA-B591663C267D
P2860
Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Concordance assessment between ...... pillomaviruse types 16 and 18.
@en
Concordance assessment between ...... pillomaviruse types 16 and 18.
@nl
type
label
Concordance assessment between ...... pillomaviruse types 16 and 18.
@en
Concordance assessment between ...... pillomaviruse types 16 and 18.
@nl
prefLabel
Concordance assessment between ...... pillomaviruse types 16 and 18.
@en
Concordance assessment between ...... pillomaviruse types 16 and 18.
@nl
P2093
P1433
P1476
Concordance assessment between ...... pillomaviruse types 16 and 18.
@en
P2093
Alfred Saah
Darron Brown
David Radley
Hanna Seitz
Ivonne Rubio
Joseph Antonello
Martin Müller
Peter Sehr
P304
P356
10.1016/J.VACCINE.2014.08.004
P407
P577
2014-08-19T00:00:00Z